These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 7343249)
81. Improving vaccination levels. Harrison J Health Visit; 1987 Jul; 60(7):227-8. PubMed ID: 3650221 [No Abstract] [Full Text] [Related]
82. [The vector of Japanese encephalitis virus (author's transl)]. Takahashi M; Ishii T; Karoji Y Uirusu; 1973 Oct; 23(3):173-83. PubMed ID: 4156984 [No Abstract] [Full Text] [Related]
83. Accelerated degradation tests on some immunological products. Kurokawa M; Ishida S; Murata R; Oya A; Sawada T; Kameyama S; Ohtani S J Biol Stand; 1979 Jan; 7(1):31-41. PubMed ID: 489620 [No Abstract] [Full Text] [Related]
84. [Influence of age on the susceptibility of mice to Japanese encephalitis virus infection (author's transl)]. Ogata T; Miura T; Ema M; Matsuda R Nihon Eiseigaku Zasshi; 1975 Aug; 30(3):411-6. PubMed ID: 1238770 [No Abstract] [Full Text] [Related]
85. [Vaccination status in Swedish preschool children]. Romanus V; Jonsell R; Böttiger M; Alvin A; Sandzelius G Lakartidningen; 1982 Aug; 79(34):2863-5. PubMed ID: 7144365 [No Abstract] [Full Text] [Related]
86. [Peripheral susceptibility of hamsters to Japanese encephalitis virus (author's transl)]. Takehara K; Mitsui T; Fukusho K; Nakamura J Uirusu; 1975; 25(4):247-52. PubMed ID: 1241964 [No Abstract] [Full Text] [Related]
87. [Principles and methods of vaccination. III]. Sumarokov AA; Kurtinkina RN Med Sestra; 1980 Jul; 37(7):48-50. PubMed ID: 6903734 [No Abstract] [Full Text] [Related]
88. Practical aspects of live virus vaccines (author's transl). Rossi E Schweiz Rundsch Med Prax; 1975 Jan; 64(4):81-3. PubMed ID: 1208346 [No Abstract] [Full Text] [Related]
89. [Observations on the reactions following vaccination of the inactivated Japanese encephalitis virus vaccine from tissue culture (author's transl)]. Zhonghua Yu Fang Yi Xue Za Zhi; 1981 Mar; 15(2):98-100. PubMed ID: 7307821 [No Abstract] [Full Text] [Related]
90. The efficacy of Japanese encephalitis vaccine in Henan, China: a case-control study. Luo D; Yin H; Xili L; Song J; Wang Z Southeast Asian J Trop Med Public Health; 1994 Dec; 25(4):643-6. PubMed ID: 7667706 [TBL] [Abstract][Full Text] [Related]
91. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen. Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893 [TBL] [Abstract][Full Text] [Related]
92. Cost benefit analysis of Japanese encephalitis vaccination program in Thailand. Siraprapasiri T; Sawaddiwudhipong W; Rojanasuphot S Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):143-8. PubMed ID: 9322297 [TBL] [Abstract][Full Text] [Related]
93. [Study on vaccination schedule of inactivated Japanese encephalitis vaccine (author's transl)]. Zhonghua Yu Fang Yi Xue Za Zhi; 1981 Nov; 15(6):360-2. PubMed ID: 7343249 [No Abstract] [Full Text] [Related]